BridgeMD
New treatment option for AMCI - Amnestic Mild Cognitive Impairment
Official title Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
ClinicalTrials.gov ID: NCT07287527
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if transcranial photobiomodulation (t-PBM), a light-based brain therapy, can help improve memory and cognitive skills in older adults with amnestic mild cognitive impairment (aMCI). This condition involves memory problems that are greater than normal aging and may increase the chance of developing Alzheimer's disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Age 55 years or older
- Diagnosis of amnestic Mild Cognitive Impairment (aMCI)
You likely can't join if
- Presence of a neurological disorder
- Presence of a severe psychiatric disorder
- Having a pacemaker or other implanted medical device that is not MRI-compatible
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
- Istnabul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye); Istnabul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.